» Articles » PMID: 37920504

Multi-omics Reveals Aging-related Pathway in Natural Aging Mouse Liver

Abstract

Aging is associated with gradual changes in liver structure, altered metabolites and other physiological/pathological functions in hepatic cells. However, its characterized phenotypes based on altered metabolites and the underlying biological mechanism are unclear. Advancements in high-throughput omics technology provide new opportunities to understand the pathological process of aging. Here, in our present study, both metabolomics and phosphoproteomics were applied to identify the altered metabolites and phosphorylated proteins in liver of young (the WTY group) and naturally aged (the WTA group) mice, to find novel biomarkers and pathways, and uncover the biological mechanism. Analysis showed that the body weights, alanine aminotransferase (ALT) and aspartate aminotransferase (AST) increased in the WTA group. The grips decreased with age, while the triglyceride (TG) and cholesterol (TC) did not change significantly. The increase of fibrosis, accumulation of inflammatory cells, hepatocytes degeneration, the deposition of lipid droplets and glycogen, the damaged mitochondria, and deduction of endoplasmic reticulum were observed in the aging liver under optical and electron microscopes. In addition, a network of metabolites and phosphorylated proteomes of the aging liver was established. Metabolomics detected 970 metabolites in the positive ion mode and 778 metabolites in the negative ion mode. A total of 150 pathways were pooled. Phosphoproteomics identified 2618 proteins which contained 16621 phosphosites. A total of 164 pathways were detected. 65 common pathways were detected in two omics. Phosphorylated protein heat shock protein HSP 90-alpha (HSP90A) and v-raf murine viral oncogene homolog B1(BRAF), related to cancer pathway, were significantly upregulated in aged mice liver. Western blot verified that protein expression of MEK and ERK, downstream of BRAF pathway were elevated in the liver of aging mice. However, the protein expression of BRAF was not a significant difference. Overall, these findings revealed a close link between aging and cancer and contributed to our understanding of the multi-omics changes in natural aging.

Citing Articles

Aging Reduces ATP-Binding Cassette Transporter Expression in Brain Microvessels of Mice.

Wada Y, Inoko M, Ishihara K, Fukumoto K, Tsurudome Y, Horiguchi M Pharmaceuticals (Basel). 2025; 18(2).

PMID: 40006002 PMC: 11859312. DOI: 10.3390/ph18020191.


Gut microbiota and metabolic profile changes unveil the deterioration of alveolar bone inflammatory resorption with aging induced by D-galactose.

Liu F, Yao Y, Huang Y, Luo L, Wang Q, Chen B Sci Rep. 2024; 14(1):26135.

PMID: 39477973 PMC: 11526011. DOI: 10.1038/s41598-024-75941-w.

References
1.
Braithwaite S, Voronkov M, Stock J, Mouradian M . Targeting phosphatases as the next generation of disease modifying therapeutics for Parkinson's disease. Neurochem Int. 2012; 61(6):899-906. DOI: 10.1016/j.neuint.2012.01.031. View

2.
Seo E, Kang H, Choi H, Choi W, Jun H . Reactive oxygen species-induced changes in glucose and lipid metabolism contribute to the accumulation of cholesterol in the liver during aging. Aging Cell. 2019; 18(2):e12895. PMC: 6413652. DOI: 10.1111/acel.12895. View

3.
Rui L . Energy metabolism in the liver. Compr Physiol. 2014; 4(1):177-97. PMC: 4050641. DOI: 10.1002/cphy.c130024. View

4.
Kim Y, Kwon O, Chae S, Jung H, Ahn S, Jeon J . Quantitative Proteomic Analysis of Changes Related to Age and Calorie Restriction in Rat Liver Tissue. Proteomics. 2017; 18(5-6):e1700240. DOI: 10.1002/pmic.201700240. View

5.
Blagosklonny M . Aging-suppressants: cellular senescence (hyperactivation) and its pharmacologic deceleration. Cell Cycle. 2009; 8(12):1883-7. DOI: 10.4161/cc.8.12.8815. View